StockWatch
·
Biotechnology: Pharmaceutical Preparations
Corporate GovernanceJul 8, 2026, 04:14 PM

Longeveron Grants Executive Chairman 600K RSUs & 400K Stock Options

AI Summary

Longeveron Inc. issued special equity awards to its Executive Chairman on July 6, 2026. These awards, approved by the Compensation Committee, recognize his significant role in the Company's March 2026 financing transaction and his continued service. The awards consist of 500,000 restricted stock units (RSUs) for the financing, and an additional 100,000 RSUs and 400,000 non-qualified stock options for continued service. All awards will vest quarterly over a three-year period commencing October 1, 2026, and convert into Class B Common Stock.

Key Highlights

  • Longeveron granted special equity awards to its Executive Chairman.
  • Awards include 500,000 restricted stock units (RSUs) for March 2026 financing.
  • Additional 100,000 RSUs granted for continued service.
  • 400,000 non-qualified stock options also granted for continued service.
  • Awards vest quarterly over a three-year period starting October 1, 2026.
  • Awards convert into Class B Common Stock, which carries five votes per share.